SQP-22

N/A

Report date: 2025/06/23 15:39:12

NME

Base Information

Drug NameSQP-22

Drug Alias NameSQP-22

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTubulin polymerisation inhibitors

TargetsTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesShasqi Inc

China Registration ClassN/A

Active CompaniesShasqi Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A